Rare diseases present a unique opportunity to rethink how innovation, evidence, and access come together across Europe. In a new Q&A with pharmaphorum, Alberta Spreafico, SVP, Health Innovation at EVERSANA, explores the evolving rare disease landscape and what it means for organizations working to bring meaningful innovation to patients.
Read the full Q&A to hear Alberta’s perspective on the opportunities ahead.